Twist Bioscience stock extends rally as bullish momentum holds above key averages

Twist Bioscience stock extends rally as bullish momentum holds above key averages
Twist Bioscience jumps 4.28% today

Twist Bioscience supported a high-resolution MHC haplotyping project with its long-read hybrid capture technology. The stock was referenced in connection with this development.

Highlights

  • TWST is demonstrating strong bullish momentum, trading at $75.42 above all major moving averages and key supports.
  • Technical indicators confirm an established uptrend, though several oscillators signal short-term overbought conditions, suggesting potential for a brief pullback or pause.
  • The projected trading range for the coming week is $73.80 to $80.50, with high probability of consolidation near new highs unless a breakout or decline breaches these levels.

Twist Bioscience thanked the authors for choosing Twist DNA for the work. Details are available in the linked source.

Sustained uptrend as moving averages and Ichimoku offer support

The current price of TWST ($75.42) is positioned well above the short-term ($59.56, SMA-20), medium-term ($56.32, SMA-50), and long-term ($40.50, SMA-200) moving averages. This confirms ongoing bullish momentum across all timeframes and reflects a robust uptrend structure. The Ichimoku Kijun on D1 stands at $60.48, which is below the current price, providing immediate support. Near-term support levels are clustered at $59.56 (SMA-20) and $56.32 (SMA-50), with key support at $50.98 (SMA-100). Immediate resistance is light, with only the recent high ($72.99, week_high) and year-to-date peak above, suggesting limited overhead supply.

Overbought momentum as price surges to weekly highs

Momentum remains positive on D1 as MACD signals buy and ADX is neutral but not weak, while the Awesome Oscillator is in support of the current trend. However, several oscillators such as RSI (70.71), Stoch RSI (100), CCI (142.8), and BBP (8.78) are in overbought territory, indicating short-term overheating and the potential for a pause or pullback. BBP reveals strong buyer dominance intraday. In today's session, TWST is up 4.28%, reflecting continued bullish sentiment. Over the past week, TWST has rallied $8.55 (12.85%) from a previous weekly close of $66.87, placing the price at the very top of the weekly range. Weekly volatility stands at 14.06%. This marks a dynamic recovery from earlier lows and strong momentum, confirmed by price action surging to new highs.

Further gains likely as consolidation holds near resistance

Looking ahead, the expected price range for the coming week is $73.80 to $80.50, anchored just below the current price and within the upper part of the annual range ($23.30–$72.99). With bullish signals from all major W1 indicators (MA-50, RSI, ADX, and MACD), the probability of a further price increase is very high (more than 80%), while the likelihood of a downward move is very low. The baseline scenario sees TWST consolidating near recent highs, trading in a sideways corridor above $73.80 and below resistance at $80.50. In a bullish scenario, a clear break above $80.50 could trigger a move into uncharted territory, continuing the uptrend. Bearish developments are less likely but would require a decisive break below $73.80, exposing lower support levels. The forecast range remains close to the 52-week high, highlighting the notable strength of recent performance.

Earlier, analysts noted that Twist Bioscience was exhibiting sustained bullish momentum, supported by technical strength and positive operational developments. Building on this outlook, investors should now monitor the sustainability of current trends and be alert to any emerging signals that could redefine the prevailing risk-reward profile.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.